Ten63 Therapeutics Raises $15.9M in Series A Financing
Funding led by: Hatteras Venture Partners with participation from Morpheus Ventures, SOSV, Draper Associates, Alexandria Venture Investments, the Sigma Group.
Total Funding Amount - $15.9M
Funds Use: To advance and expand its internal pipeline of first-in-class small molecules inhibiting high-impact cancer targets, including continued progression of its